Royal Bank Of Canada Cara Therapeutics, Inc. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

A detailed history of Royal Bank Of Canada transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 449 shares of CARA stock, worth $139. This represents 0.0% of its overall portfolio holdings.

Number of Shares
449
Previous 4,550 90.13%
Holding current value
$139
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.26 - $0.38 $1,066 - $1,558
-4,101 Reduced 90.13%
449 $0
Q2 2024

Aug 14, 2024
BUY
$0.24 - $0.92 $732 - $2,808
3,053 Added 203.94%
4,550 $1,000
Q1 2024

Nov 05, 2024
SELL
$0.52 - $1.05 $1,587 - $3,205
-3,053 Reduced 67.1%
1,497 $1,000
Q1 2024

May 15, 2024
SELL
$0.52 - $1.05 $7,297 - $14,735
-14,034 Reduced 90.36%
1,497 $1,000
Q4 2023

Feb 14, 2024
BUY
$0.6 - $1.65 $4,337 - $11,927
7,229 Added 87.08%
15,531 $11,000
Q3 2023

Nov 14, 2023
BUY
$1.67 - $3.33 $4,964 - $9,900
2,973 Added 55.79%
8,302 $13,000
Q2 2023

Aug 14, 2023
BUY
$2.83 - $4.94 $4,437 - $7,745
1,568 Added 41.69%
5,329 $15,000
Q1 2023

May 15, 2023
SELL
$4.89 - $12.27 $15,022 - $37,693
-3,072 Reduced 44.96%
3,761 $18,000
Q4 2022

Feb 14, 2023
BUY
$8.88 - $12.77 $30,067 - $43,239
3,386 Added 98.23%
6,833 $73,000
Q3 2022

Nov 14, 2022
BUY
$8.24 - $12.56 $5,364 - $8,176
651 Added 23.28%
3,447 $32,000
Q2 2022

Aug 15, 2022
SELL
$7.45 - $13.84 $22,588 - $41,962
-3,032 Reduced 52.02%
2,796 $25,000
Q1 2022

May 16, 2022
SELL
$9.94 - $12.65 $37,275 - $47,437
-3,750 Reduced 39.15%
5,828 $70,000
Q4 2021

Feb 14, 2022
BUY
$11.99 - $18.14 $33,080 - $50,048
2,759 Added 40.46%
9,578 $116,000
Q3 2021

Nov 15, 2021
BUY
$11.55 - $16.06 $8,997 - $12,510
779 Added 12.9%
6,819 $105,000
Q2 2021

Aug 16, 2021
BUY
$12.38 - $29.19 $74,775 - $176,307
6,040 New
6,040 $86,000

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $16.7M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email